Post-approval studies (Phase 4)Ended earlyNCT03591770
What this trial is testing
Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib
Who this might be right for
Inflammatory Bowel Diseases
Boston Medical Center 15
Showing 20 of 0 results